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Single-cell transcriptomics reveals distinct
inflammation-induced microglia signatures
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Abstract
Microglia are specialized parenchymal-resident phagocytes of the
central nervous system (CNS) that actively support, defend and
modulate the neural environment. Dysfunctional microglial
responses are thought to worsen CNS diseases; nevertheless, their
impact during neuroinflammatory processes remains largely
obscure. Here, using a combination of single-cell RNA sequencing
and multicolour flow cytometry, we comprehensively profile
microglia in the brain of lipopolysaccharide (LPS)-injected mice. By
excluding the contribution of other immune CNS-resident and
peripheral cells, we show that microglia isolated from LPS-injected
mice display a global downregulation of their homeostatic
signature together with an upregulation of inflammatory genes.
Notably, we identify distinct microglial activated profiles under
inflammatory conditions, which greatly differ from neurodegenera-
tive disease-associated profiles. These results provide insights
into microglial heterogeneity and establish a resource for the iden-
tification of specific phenotypes in CNS disorders, such as neuro-
inflammatory and neurodegenerative diseases.
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Introduction
The healthy brain hosts distinct and specialized populations
of tissue-resident macrophages strategically placed in the
parenchyma, perivascular spaces, meninges and choroid plexus
where they coordinate homeostatic and immune surveillance func-
tions [1]. As the only parenchymal-resident immune cells of the
central nervous system (CNS), microglia act as critical effectors
and regulators of changes in the CNS during development and
adult homeostasis. Their ontogeny, together with the absence of
turnover from the periphery and the exceptional environment of
the CNS, makes microglia a unique immune cell population [2]. By
sensing any disruption of CNS homeostasis, microglia rapidly
change their gene expression programmes and functional profiles.
Recent genome-wide transcriptional studies revealed a unique
molecular signature selectively expressed in homeostatic microglia
[3–6] that is lost in disease and during ageing [4,7–17]. Microglia
coordinate immune responses between the periphery and the CNS
as they perceive and propagate inflammatory signals initiated
outside the CNS [18]. A multitude of signals received from the
CNS environment as well as from the periphery induce microglial
responses towards phenotypes that ultimately may support or
harm neuronal health [2,19]. Although neuroinflammation and its
associated immune responses are often linked to neurodegenera-
tion, the inflammatory response per se provides a primary,
transient and self-limiting defence mechanism, by which harmful
stimuli are resolved and tissue damage is repaired [20]. Disruption
of CNS homeostasis, neuronal deterioration and inflammation are
common pathophysiological features of several neurodegenera-
tive diseases. In this context, chronic inflammation is likely to
be triggered by abnormal protein deposition, by signals elicited by
injured neurons and synapses or by impaired pro- and anti-inflam-
matory regulatory mechanisms that ultimately exacerbate the
neurodegenerative process [21]. Dysfunctional microglial responses
are believed to worsen CNS diseases [22]; nevertheless, their
impact during the neuroinflammatory processes remains largely
obscure.
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In recent years, single-cell RNA sequencing investigations have
emerged as a remarkable method to depict heterogeneous cell
populations and measure cell-to-cell expression variability of
thousands of genes [23–25]. In the murine and human brains,
single-cell RNA sequencing analyses have revealed neural and
glial cell heterogeneity [26–30]. Similarly, the complexity of
immune cell types has been recently unravelled [31]. However,
although recent studies have elucidated microglia signatures asso-
ciated with inflammatory conditions at the bulk level [4,16,32], it
is still not clear whether all microglial cells uniformly react to the
inflammatory stimuli.
To elucidate the heterogeneity of microglial responses towards
systemic inflammation, we here analysed the effect of a peripheral
injection of the Gram-negative bacterial endotoxin lipopolysaccha-
ride (LPS) in 3- to 4-month-old C57BL/6N mice using a combination
of multicolour flow cytometry and single-cell RNA sequencing anal-
yses. LPS is a well-known immunostimulant used to mimic
inflammatory and infectious conditions inducing immune responses
associated with sickness behaviour in mice and humans [33,34].
Notably, it has been shown that repeated peripheral injections of
LPS in mice induce neurodegeneration, while a single-dose injection
of LPS induces acute inflammatory, but not neurodegenerative
processes [35]. By our approach, we have identified distinct micro-
glial activated profiles under acute inflammatory conditions, which
differ from the recently described disease-associated phenotypes
[14].
Understanding the specific molecular triggers and the subsequent
genetic programmes defining microglia under homeostatic,
inflammatory and neurodegenerative conditions at the single-cell
level is a fundamental step to further uncover the multifaceted
nature of microglia, thus opening new windows to design novel
therapeutic strategies to restore, for example, efficient inflammatory
immune responses in CNS diseases.
Results and Discussion
Acutely isolated CD11b+CD45int cells express high levels of
microglial homeostatic genes and represent a specific resident
immune cell population
Cell-specific transcriptomic analyses are critically dependent on
isolation protocols to obtain pure populations resembling their phys-
iological profiles. To characterize microglia close to their proper
environment, mouse brains were mechanically dissociated into
single-cell suspension with all the steps performed at 4°C [36]. Since
microglia in the mouse brain represent only 10% of the cells,
CD11b+CD45int microglia were purified from other CNS and
immune cells, including CD11b+CD45high macrophages and
CD11bCD45high lymphocytes, by FACS, as described previously
(Figs 1A and EV1) [37]. To verify accurate microglial enrichment,
we compared gene expression levels of specific CNS cell type mark-
ers between RNA extracted from unsorted total brain cells and
CD11b+CD45int sorted microglia (Fig 1B). We analysed the expres-
sion levels of microglial homeostatic genes (Olfml3, Fcrls,
Tmem119, Siglech, Gpr34, P2ry12) as well as astrocytic (Gfap, Gjb6,
Ntsr2, Aldh1l1), oligodendrocytic (Mobp, Mog, Cldn11) and
neuronal (Tubb3, Vglut1, NeuN) markers. As expected, microglial
markers were highly expressed in CD11b+CD45int sorted cells,
whereas astrocytic, oligodendrocytic and neuronal markers were
undetectable or detectable at background levels (Figs 1B and EV1).
We next investigated whether CD11b+CD45int population contained
resident non-parenchymal macrophages, such as perivascular
macrophages. This was inferred using CD206 as an additional
marker for resident macrophages [38]. Under homeostatic condi-
tions, CD11b+CD45int microglia contained only 0.04  0.02%
CD206+ cells, while CD11b+CD45high cells contained 24.7  3.8%
CD206+ resident macrophages (Fig 1C and D). Similar results were
obtained for the dendritic cell marker CD11c and the monocytic
markers Ly6C and CCR2 (Fig EV1). Taken together, these results
show that our approach highly discriminates pure and not activated
microglial populations from other resident CNS cells.
Microglia isolated from LPS-injected mice show a classical
activated pro-inflammatory profile accompanied by a decreased
homeostatic signature
The response of microglia towards specific pro- or anti-inflamma-
tory cues in vitro has been extensively studied [39]. Treatment of
primary microglial cells with TGF-b, LPS or IL-4 generates, respec-
tively, the so-called M0 homeostatic, M1 pro-inflammatory and M2
anti-inflammatory states defined by specific gene signatures [5,40].
However, our understanding towards the reaction of microglia
under inflammatory conditions in vivo is only starting to emerge. To
comprehensively investigate the effect of a systemic inflammatory
and/or infectious state on microglia, we peripherally injected mice
with LPS (4 lg/g body) 24 h prior analysis. It has been shown that
a single-dose injection of LPS induces acute inflammatory, but not
neurodegenerative processes [35]. We isolated CD11b+CD45int cells
from LPS-injected mice and compared mRNA levels of specific genes
▸Figure 1. Characterization of acutely isolated CD11b+CD45int cells.A FACS gating strategy representative of five independent experiments adopted to sort CD11b+CD45int microglia distinctly from CD11b+CD45high resident macrophages
and CD11bCD45high lymphocytes.
B Analysis of relative transcript levels of CD11b+CD45int FACS-sorted microglia compared with whole brain tissue by qPCR. Gene expression levels of microglia (Olfml3,
Fcrls, Tmem119, Siglech, Gpr34, P2ry12), astrocyte (Gfap, Gjb6, Ntsr2, Aldh1l1), oligodendrocyte (Mobp, Mog, Cldn1) and neuron (Tubb3, Vglut1, NeuN) markers. Bars
represent mean (n = 4; pool of one female and one male per biological replicate) of relative expression (Gapdh as housekeeping gene)  SEM (*P < 0.05; **P < 0.01
by two-tailed Student’s t-test). N.D., not detected.
C Representative quantification of CD206 expression in CD11b+CD45int microglia and CD11b+CD45high resident macrophages. Values denote the percentage of the
mean  SEM of five independent experiments.
D Representative images of two independent experiments showing microglia, resident macrophages and lymphocytes acquired with ImageStream imaging cytometer
(Amnis) based on CD45, CD11b and CD206 expression levels (scale bar represents 7 lm).
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to the corresponding cells isolated from saline-injected control mice
by qPCR. In agreement with previous studies [32,41], the expression
levels of homeostatic (e.g. Olfml3, Fcrls, Tmem119, Siglech, Gpr34,
P2ry12, Mef2c), phagocytic (Tyrobp and Trem2) and anti-inflamma-
tory genes (e.g. Mrc1 and Arg1) were highly decreased in microglia
isolated from LPS-injected mice compared to untreated mice, while
the classical pro-inflammatory genes (e.g. Il1b, Tnf and Ccl2) were
markedly increased (Figs 2A and EV2). Notably, it has been recently
shown that signals from the CNS microenvironment have consider-
able influence in shaping, maintaining and reinforcing microglial
identity by regulating expression and establishing distinct chromatin
landscapes surrounding enhancer regions [42–44]. Changes in chro-
matin remodelers associate with changes in the expression of
nearby genes. Specifically, MEF2C binding sites were shown to be
over-enriched in enhancer regions of microglial-specific genes [42]
and the loss of MEF2C was associated with priming of microglia
[45]. In line with these observations, Mef2c expression levels were
highly decreased in microglia isolated from LPS-injected mice
compared to naı¨ve mice.
We verified that this signature is microglia-specific, and it is not
affected by LPS-activated immune peripheral cells, such as lympho-
cytes (CD11bCD45high cells) and peripheral monocytes/macro-
phages (CD11b+CD45high cells), as no significant differences were
detected between cellular populations present in brains of saline-
and LPS-injected mice (Figs 2B and EV2). Importantly,
CD11b+CD45int FACS-gated cells contained very rare (< 0.25%)
Ly6C+ putative monocytes and (< 0.1%) CD206+ putative resident
macrophages (Fig 2C). Also, the expression of monocytic markers
Ly6c1 and Ccr2 was very low in CD11b+CD45int microglia compared
to bone marrow-isolated monocytes with no significant differences
under LPS exposure (Figs 2D and EV2). In order to further assess
that the decrease in the homeostatic signature under inflammatory
conditions is not due to the presence of other immune cell types,
but it is an intrinsic property of microglial cells, we also analysed
the effect of LPS on cultivated microglial from adult and neonatal
mice. As expected, the expression level of the homeostatic genes
was markedly decreased in cultivated cells when compared to
acutely isolated microglia (Fig EV2) [5]. Thus, we cultivated adult
microglia in the presence of TGF-b (50 lg/ml) and M-CSF (10 ng/
ml) or neonatal cells with TGF-b 24 h prior treatment with LPS to
induce the expression of the homeostatic genes, although at a lower
extent than in ex vivo isolated cells (Fig EV2). Cells treated with LPS
(1 ng/ml) for 6 h showed a dramatic decrease of the expression
levels of the homeostatic gene markers, such as Olfml3, Tmem119
and Gpr34, accompanied by enhanced expression levels of
inflammatory marker genes, such as Il1b, Tnf and Ccl2 both in adult
and in neonatal microglia when compared to cells treated with
TGF-b only (Fig 2E). In the healthy brain, TGF-b is expressed at low
levels by both neurons and glial cells [46,47], while its expression is
increased upon injury [48,49], hypoxia–ischaemia [50] and
neurodegeneration [51,52]. SMAD and signal transducer and activa-
tor of transcription (STAT) proteins are key signal transducers and
transcription factors controlling TGF-b downstream signalling [53].
Specifically, STAT3 and suppressor of cytokine signalling 3 (SOCS3)
regulate inflammatory responses [54]. The binding of SOCS3 to both
JAK kinase and the cytokine receptor results in the inhibition of
STAT3 activation. In our analysis, microglial cells treated with LPS
showed increased amounts of STAT3 phosphorylation along with
upregulation of Socs3 expression levels compared to untreated cells
(Appendix Fig S1). Taking advantage of the “harmonizome” collec-
tion of databases [55], we attested that more than 1/3 of the top 100
sensome genes [4] possess STAT3-binding sites in their promoter
region. Hence, we hypothesized that the SOCS3-STAT3 antagonistic
signalling may be responsible for the suppression of the homeostatic
microglia signature and the concomitant shift towards the
inflammatory profile [56].
These results show that microglia isolated from LPS-injected
mice display a classical activated pro-inflammatory profile associ-
ated with a decrease in the expression of the homeostatic genes.
The decrease in the homeostatic signature under inflammatory
conditions is an inherent facet of microglial in vivo and in vitro.
Single-cell mRNA sequencing of CD11b+CD45int microglia isolated
from LPS-injected mice reveals a global transcriptional shift and
increased heterogeneity compared to steady state conditions
Based on the observed differences in the targeted qPCR approach
under steady state and LPS conditions, we next aimed to investigate
microglial states at the genome-wide level and infer their transcrip-
tomic heterogeneity at single-cell resolution, since studying a popu-
lation of cells masks the differences among individual cells. For this
purpose, FACS-sorted CD11b+CD45int cells from saline- or LPS-
injected mice were analysed using the recently developed high-
throughput droplet-based Drop-seq method [23]. In Drop-seq,
single cells and functionalized barcoded beads as cell identifiers
are co-encapsulated into droplets followed by cDNA synthesis,
▸Figure 2. LPS stimulation induces an intrinsic loss of the microglia homeostatic signature.A–D Three- to four-month-old C57BL/6N mice were treated with an acute dose of LPS (4 lg/g body) or vehicle (saline). Microglia (pool of two mice per group per
replicate; one female and one male) were FACS-sorted 24 h later. (A) Gene expression levels of microglial homeostatic (Olfml3, Fcrls, Tmem119, Siglech, Gpr34,
P2ry12, Mef2c), phagocytic (Tyrobp, Trem2) and inflammatory (Il1b, Tnf, Ccl2, Mrc1, Arg1) markers were analysed by qPCR. Bars represent mean of relative expression
(% of saline; Gapdh as housekeeping gene)  SEM (*P < 0.05; **P < 0.01 by two-tailed Student’s t-test; n = 4). (B) Representative multicolour flow cytometry
analysis of five independent experiments showing CD11b- and CD45-positive populations in single viable cells in saline or LPS-injected mouse brains. (C)
Representative multicolour flow cytometry analysis showing the percentage of the mean  SEM of five independent experiments of Ly6C- and CD206-expressing
cells in CD11b+CD45int cells from saline or LPS-injected mice. (D) Gene expression levels of the monocytic markers Ly6c1 and Ccr2 in purified microglia (n = 4) and
isolated bone marrow monocytes (n = 2) by qPCR. Bars represent mean of relative expression (Gapdh as housekeeping gene)  SEM (**P < 0.01 by two-tailed
Student’s t-test).
E Primary adult microglia were cultivated in the presence of TGF-b (50 lg/ml) and M-CSF (10 ng/ml), while neonatal cells were stimulated for 24 h with TGF-b
(50 lg/ml) followed by 6 h of stimulation with LPS (1 ng/ml) or left untreated. Expression levels of microglial homeostatic (Olfml3, Tmem119, Gpr34) and
inflammatory (Il1b, Tnf, Ccl2) genes were analysed by qPCR. Bars represent mean of relative expression (Gapdh as housekeeping gene)  SEM (*P < 0.05; **P < 0.01
by two-tailed Student’s t-test).
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amplification, library preparation and next-generation sequencing.
First, we sought for differentially expressed genes between all LPS
and all naı¨ve/saline cells using MAST [57]. We identified 2,405 dif-
ferentially expressed genes between these two conditions with a
false discovery rate (FDR) cut-off of 5% (Dataset EV1) and exempli-
fied the top 100 differentially expressed genes in a heatmap
(Fig 3A). Second, principal component analysis followed by two-
dimensional t-distributed stochastic neighbour embedding (2D-
tSNE) of the overall gene expression data of 1,247 analysed cells
identified two main cell clusters that were independent of the 2D-
tSNE parameters and library sizes (Appendix Fig S2). Microglia
isolated from LPS-injected mice distinctly clustered from the corre-
sponding steady state microglia presenting discrete gene expression
signatures (Fig 3B; Dataset EV1). Intriguingly, we noticed from both
analyses that, although most of the activated cells clustered
together, a small group of cells assembled closer to the control cells,
thus highlighting the existence of potential subpopulations under
inflammatory conditions, which we characterized later. Gene set
enrichment analysis (GO) of upregulated genes in microglia isolated
from LPS-injected mice using DAVID [58,59] uncovered significant
involvement (P < 2.5 × 109) in “translation”, “protein folding”,
“ribosome biogenesis” and “immune system process”, thus
reflecting highly activated cells. On the other hand, GO of the corre-
sponding downregulated genes identified, among others, significant
enrichment (P < 4.9 × 105) in “regulation of transforming growth
factor beta receptor signalling pathway”, thus reflecting that TGF-b
signalling is among the most affected pathways in microglia exposed
to LPS (Appendix Fig S3). In line with gene expression results
obtained at the bulk level, microglial homeostatic genes (e.g.
Tmem119, Mef2c, P2ry13, P2ry12, Siglech) were among the top
downregulated genes and classical pro-inflammatory genes (e.g.
Ccl2, Gpr84, Nfkbia) were mainly upregulated also at the single-cell
level (Appendix Fig S2). We further investigated individual gene
expressions at single-cell level using 2D-tSNE to show specific
homeostatic and inflammatory gene expression levels. For example,
Tmem119, Siglech and P2ry12 genes were consistently expressed
under steady state, but were downregulated in microglia isolated
from LPS-injected mice, while Ccl2 and Gpr84 were largely upregu-
lated in most of the cells exposed to LPS compared to saline condi-
tions (Fig 3C; Appendix Fig S4). Notably, a prominent decrease in
TMEM119 and P2RY12 expression was further confirmed at the
protein level by flow cytometry (Fig 3D).
Although microglial activation is a common hallmark under
inflammatory and neurodegenerative conditions [22], microglia
transcriptional signatures have been shown to be different. For
example, Chiu et al [16] demonstrated that acutely isolated micro-
glia from the SOD1G93A mouse model of amyotrophic lateral sclero-
sis (ALS) differed from LPS-activated microglia, defining an ALS-
specific phenotype. Following the recent description of a novel
disease-associated microglial (DAM) phenotype identified under
neurodegenerative conditions at single-cell resolution [14], we here
compared our inflammatory-associated microglia (IAM) signature to
DAM. The scatterplot showing the fold change of genes between
microglia isolated from LPS-injected mice (2,405 genes; Dataset
EV1) versus DAM (1,660 genes; Dataset EV2) compared to homeo-
static microglia (FDR < 0.05) disclosed 1,826 unique genes affected
by the LPS treatment (e.g. Tnf, Irf1), 1,081 distinct genes in DAM
(e.g. Itgax, Axl) and 579 shared genes between the two populations
(e.g. Gpr84, Tmem119), thus highlighting that these cells mainly
display a unique expression profile (Fig EV3). Specifically, only
215 upregulated genes (12.1%) and 364 downregulated genes
(21.2%) were shared between the two groups (Fig EV3). Gene set
enrichment analysis (GO) and identification of key genes being
discriminative between inflammatory microglia and DAM revealed
a high inflammatory reactivity upon LPS treatment and a phago-
cytic/lysosomal gene signature in DAM (Fig EV3). For instances,
Trem2 and Tyrobp expression levels were highly decreased in
IAM, whereas an elevation of both genes was reported in DAM.
TREM2 associates with the immunoreceptor tyrosine-based activa-
tion motif (ITAM)-containing adaptor protein TYROBP (DAP12),
in which signalling involves the recruitment of tyrosine kinase
Syk that further phosphorylates downstream pathways inducing
cell activation. TREM2 is required for phagocytosis of apoptotic
neurons, microglial proliferation and survival [56,60–62]. These
subtle differences in perceiving different signals induced by CNS
perturbations support the microglial critical role in modulating
specific functional activities. In fact, it is intuitive to consider that
sensing inflammatory environments to maintain a homeostatic
neuronal network (e.g. through the expression of Clec4a and
Clec5a genes that are exclusively upregulated in our dataset) or
recognizing and clearing pathogenic factors (e.g. by expressing
Clec7a/Dectin-1 in DAM), such as b-amyloid aggregates in AD,
require distinct activated phenotypes. In a different context, it has
been recently shown that myelin pieces are gradually released
from ageing myelin sheaths and are subsequently cleared by
microglia [63]. Age-related myelin fragmentation is substantial,
leading to lysosomal storage and contributing to microglial senes-
cence and immune dysfunction in ageing [63]. It could be then
hypothesized that a similar accentuated mechanism may be
encountered by microglia surrounding b-amyloid plaques, which
become dystrophic at a late stage of the disease [64]. Interest-
ingly, genes described to be associated with neurological diseases,
such as Cd33, Cd9, Sod1, Ctsd, and Hif1a, were also downregu-
lated in our signature in comparison with DAM.
Taken together, these results suggest that microglia under acute
systemic inflammation present a highly activated state, which is
heterogeneous and distinct from neurodegenerative disease-
associated profiles.
Microglia present distinct activated signatures under
inflammatory conditions
Next, we aimed to elucidate whether the response to LPS was
heterogeneous across microglial cells. Based on our previous obser-
vation (Figs 3A and B), we further analysed the identified subclus-
ters by 2D-tSNE representation (Fig 4A). Based on the obtained 2D
representation, a specific LPS subgroup (“subset LPS”, in yellow)
distinct from the core LPS cluster (“main LPS”, in red) was identi-
fied closer to naı¨ve microglial cluster. Thus, we hypothesized that
these cells may correspond to a microglial subset that is less sensi-
tive to inflammatory stimuli or a cluster of cells which already partly
recovered from their activated state following the prominent pro-
inflammatory immune response. We obtained differentially
expressed genes between the “main LPS” (Dataset EV3) and the
“subset LPS” (Dataset EV4) clusters compared to the corresponding
control conditions (FDR < 0.05). We represented the top 100
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Figure 3. Characterization of microglial activation at the single-cell level.
A Heatmap showing clustering analysis of 1,247 single cells, featuring 100 most variable genes (FDR < 0.05). Single-cell RNA-seq results are obtained from two mice
per group (one female and one male each). Values denote a score based on gene expression rank.
B 2D-tSNE representation of all single cells included in the study (n = 1,247) depicting the separation of microglia isolated from LPS-injected mice (770 cells in red) and
steady state (477 cells in blue) in two main clusters.
C Expression of specific homeostatic (Tmem119, P2ry12, Siglech) and inflammatory (Ccl2, Gpr84) genes overlaid on the 2D-tSNE space. Bars represent log2 (Count + 1).
D Representative multicolour flow cytometry analysis of two independent experiments showing TMEM119 and P2RY12 expression levels in CD11b+CD45int microglia of
saline or LPS-injected mouse brains. For the unconjugated TMEM119 antibody, negative stands for primary antibody without secondary antibody. For P2RY12
antibody, negative represents isotype PE control.
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differentially expressed genes among the identified clusters in a
heatmap (FDR < 0.05; Appendix Fig S5). To elucidate the transcrip-
tional signature of the LPS subgroups, we showed differentially
expressed genes between “main LPS” and “subset LPS” clusters
compared to the corresponding control conditions (FDR < 0.05). In
line with their activated state, the main pro-inflammatory genes
(e.g. Ccl2, Tnf, Irg1, Gpr84) were upregulated (Fig 4B) and the
microglial homeostatic genes (e.g. Siglech, P2ry12, Fcrls, Gpr34)
were downregulated in both populations (Fig 4C), although at a
lesser extent in “subset LPS”, compared to steady state conditions.
Investigation of the top differentially expressed genes unique to
“main LPS” or “subset LPS” compared to naı¨ve cells (FDR < 0.05;
Log2FC ≥ 3 or Log2FC ≤ 3; Table 1) identified, for example, Manf
(a growth factor that promotes neuroprotection and tissue repair
[65]) and C5ar1 among the top upregulated genes in “main LPS”
and Stab 1 as well as Ash1l (which suppresses the production of
pro-inflammatory mediators, such as IL-6 and TNF [66]), among the
enhanced genes in “subset LPS”. Downregulated genes were, for
example, the homeostatic gene marker Mef2c, which restrains the
microglial inflammatory response [45] in “main LPS” and genes
associated with endosomes/lysosomes in both “main LPS” (Maf)
and “subset LPS” (Lamp1) (Figs 4D and EV4), thus potentially
providing some mechanistic insights regarding the less activated
state of “subset LPS” compared to the “main LPS” cluster. Further
analysis of unique differentially expressed genes (FDR < 0.05) char-
acterizing the two LPS subpopulations based on microglial functions
and properties showed a dramatic increase in genes associated with
the major histocompatibility complex (e.g. H2-D1 and H2-K1) exclu-
sively in the “main LPS” group and a decrease in the complement
system (e.g. C1qa, C1qb and C1qc) in the “subset LPS” group when
compared to steady state (Table EV1).
Notably, we characterized membrane markers corresponding to
specific genes identified at single-cell resolution by flow cytometry
to analyse the expression levels of markers upregulated in both LPS
groups (e.g. CD44), only in “main LPS” (e.g. CD274) or only in
“subset LPS” (e.g. NOTCH4). Although three markers used simulta-
neously did not allow to clearly discriminate the “subset LPS” from
the “main LPS” population, changes in the proportion of marker-
positive cells were in line with the scRNA-seq data. Upon LPS treat-
ment, a smaller proportion of NOTCH4-positive cells (saline 5.4%;
LPS 18.9%) compared to CD44 (saline 65.2%; LPS 97.5%) and
CD274 (saline 48.7%; LPS 88.1%) were detected (Fig EV5). We con-
firmed this pattern by immunohistochemistry, showing that
NOTCH4-positive cells were evenly distributed throughout the
brain, thus indicating that these cells were not associated with a
specific brain region (Fig EV5).
Gene set enrichment analysis of downregulated genes character-
izing “subset LPS” compared to “main LPS” confirmed “innate
immune response” and “complement activation, classical pathway”
as decreased terms, thus highlighting a less pronounced activated
state of the “subset LPS”. Intriguingly, these cells revealed signifi-
cant over-representation (P < 0.05) of “covalent chromatin modifi-
cation” and “DNA repair” that may indicate cells recovering from
their acute activated state or a subset of cells with specific chro-
matin states and DNA repair properties conveying an attenuated
activated phenotype than the main population (Fig 4E). In order to
further corroborate the existence of the identified microglial subpop-
ulations under inflammatory conditions, the corresponding 770 cells
were subjected to the “SC3” method [67]. With two clusters, we
found a very high concordance between the subcluster obtained
with “SC3” and the LPS subset identified by 2D-tSNE, thus support-
ing the existence of the detected subpopulations. We represented
the top 50 differentially expressed genes driving the segregation of
cells into the two clusters in a heatmap (adjusted P-value < 0.05;
Appendix Fig S6).
◀ Figure 4. Identification of microglial subpopulations under inflammatory conditions.A 2D-tSNE representation of 1,247 single cells isolated from naïve (blue)- and LPS-treated mice showing two distinct subpopulations among the 770 cells isolated from
LPS-injected mice (n = 703, red; n = 67, yellow).
B Venn diagram showing 732 genes uniquely upregulated in the “main LPS” cluster (red) and 241 genes exclusively increased in the “subset LPS” (yellow) compared to
their corresponding controls (blue) (FDR < 0.05). A total of 274 genes were shared between the two LPS populations.
C Venn diagram showing 1,055 genes uniquely downregulated in the “main LPS” cluster (red) and 29 genes exclusively decreased in the “subset LPS” (yellow) compared
to their corresponding controls (blue) (FDR < 0.05). A total of 87 genes were shared between the two LPS populations.
D Heatmap showing examples of specific genes mainly upregulated in “main LPS” (Manf) or “subset LPS” (Ash1l) and downregulated in “main LPS” (Mef2c) or “subset
LPS” (Lamp1) overlaid on the 2D-tSNE space. Bars represent log2 (Count + 1).
E Gene set enrichment analysis (GO, top 10 biological processes) of 99 downregulated and 397 upregulated genes distinguishing cells in “subset LPS” versus “main LPS”
(FDR < 0.05).
Table 1. List of top differentially expressed genes unique to “main
LPS” or “subset LPS” versus PBS (FDR < 0.05; upregulated genes,
Log2FC ≥ 3; downregulated genes, Log2FC ≤ 3).
Top upregulated genes Top downregulated genes
“Main LPS” “Subset LPS” “Main LPS” “Subset LPS”
Rplp0 Gm26924 Tanc2 Lamp1
Rps2 Golga4 Pde3b Gm17087
Cd52 Zfc3h1 Maf Cd68
Cd63 RP24-312B12.1 Rasgrp3 Rps14
Ctsl Stab 1 Zfhx3 C1qc
Manf Cacna1d 4632428N05Rik Itm2c
Pdia4 Ash1l Mef2c Eif1
Calm1 Ascc3 Qk H3f3b
Rps19 Atrx Ivns1abp Cd81
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Lastly, we used Venn diagrams to show unique and common
upregulated and downregulated (Fig EV5) genes among “main LPS”
cluster, “subset LPS” and DAM (FDR < 0.05). Among the deregu-
lated genes, for example, Spp1, Il1b and Tlr2 were commonly upreg-
ulated, while Fcrls, Tgfbr1 and Siglech were downregulated in the
three groups. Intriguingly, genes of the complement system (e.g.
C1qa, C1qb and C1qc) were downregulated in both “subset LPS”
and DAM, but not in “main LPS”. Further analysis of the top
differentially expressed genes unique to the three groups compared
to naı¨ve cells (FDR < 0.05; Log2FC ≥ 3 or Log2FC ≤ 3;
Appendix Table S1) showed that the previously identified genes,
such as Manf and C5ar1 are uniquely upregulated in “main LPS”,
while Stab 1 as well as Ash1l is among the increased genes only in
“subset LPS”.
Overall, these results highlight the existence of specific microglial
subpopulations under inflammatory conditions, which are distinct
from neurodegenerative-associated phenotypes. These findings
emphasize heterogeneity of microglial activated states in vivo
reflecting specific functional activities related to their corresponding
environment.
Pseudotime analysis of LPS-activated microglia uncovers “subset
LPS” as an intermediate activated state
Although further analyses at different time points should be
performed in the future to resolve the dynamic process of activation,
to further investigate the activation process, the heterogeneity
within LPS-activated microglia and, specifically, the properties of
“subset LPS” compared to “main LPS”, we applied branch expres-
sion analysis modelling (BEAM) and corresponding pseudotime
analysis implemented in Monocle 2 [68]. Since the more subtle dif-
ferences during the activation process would be dominated by the
large differences between naı¨ve and LPS conditions, we applied the
branching analysis to the LPS-activated microglia only. This more
sensitive analysis revealed nine different states, with the largest dif-
ference of “subset LPS” to all others, in accordance with the previ-
ous tSNE and “SC3” analyses. Interestingly, cells assigned to
“subset LPS” exhibit a dense core, but also a significant number of
cells towards the other main clusters (Fig 5A). Given this more
sensitive clustering and corresponding pseudotime analysis, we then
investigated the characteristics of “subset LPS” with respect to their
activation state and their relation with the other states. For this
purpose, we plotted the estimated pseudotime of each cell in the
state space indicating a delayed activation pattern of “subset LPS”
(Fig 5B). Lastly, we investigated inflammatory (e.g. Ccl12, Ccl2,
Gpr84) and homeostatic (e.g. Mef2c, P2ry12, Siglech) gene expres-
sion profiles in dependence on pseudotime, further indicating the
delayed activation state of “subset LPS” by smaller pseudotimes
(Fig 5C). By comparing the dynamics of the inflammatory and
homeostatic genes along the activation process, we observed that
inflammatory genes were upregulated first, while the homeostatic
markers were only subsequently downregulated. Thus, “subset
LPS” may correspond to an intermediate state where the gene
expression levels of the inflammatory mediators are increased, but
the homeostatic gene markers, such as Mef2c, are still partly
preserved. In conclusion, from this analysis, we hypothesized that
these cells may correspond to a microglial subpopulation that is less
sensitive to inflammatory stimuli.
In summary, our work elucidated an extensive picture of micro-
glial profiles in steady state and upon inflammatory conditions,
including unforeseen heterogeneity in their states of activation. We
believe that our findings, together with the recent single-cell RNA
sequencing studies of microglia in Alzheimer’s disease [14], present
a comprehensive transcriptomic view of microglia under acute
inflammatory conditions and a comparison with neurodegenerative
processes. These results could then pave the way to design new
therapeutic approaches to restore abnormal or detrimental micro-
glial phenotypes found in several CNS disorders.
Materials and Methods
Animals
Three- to four-month-old C57BL/6N male and female mice were
obtained from Charles River Laboratories (France). Mice were
housed in 12-h light/dark cycle, with sterile food and water ad libi-
tum. All animal procedures were approved by the University of
Luxembourg Animal Experimentation Ethics Committee and by
appropriate government agencies. The animal work of the present
study has been conducted and reported in accordance with the
ARRIVE (Animal Research: Reporting of In Vivo Experiments) guide-
lines to improve the design, analysis and reporting of research using
animals, maximizing information published and minimizing unnec-
essary studies.
Acute microglial isolation and purification by multicolour
flow cytometry
Mice were treated with a single intraperitoneal injection of LPS
(4 lg LPS/g body weight) or with PBS (saline) as vehicle control.
Twenty-four hours later, mice were deeply anaesthetized with a
combination of ketamine (100 mg/ml; Nimatek Vet)–dorbene
(medetomidine hydrochloride; 1 mg/ml; Dorbene Vet) and perfused
transcardially with ice-cold PBS. Further processing was performed
at 4°C and no-break centrifugations. Brains were rapidly removed,
stored in ice-cold HBSS (Gibco/Life Technologies) with 1 M HEPES
(Gibco/Life Technologies) and 0.5% D-(+)-glucose (Sigma-Aldrich),
mechanically homogenized in a potter homogenizer and centrifuged
at 900 rpm for 10 min. Myelin was removed from cell suspension
with the Myelin Removal Kit (Miltenyi Biotec) according to the
manufacturer’s protocol. Prior to the FACS, the cell suspension was
◀ Figure 5. Pseudotime analysis.A Branching analysis of LPS-activated microglia by Monocle 2 leads to nine distinct clusters in a two-dimensional state space inferred by generalized regression
modelling (see Materials and Methods) showing the major difference of “subset LPS” (in yellow) compared to the other clusters corresponding to “main LPS” (in red).
B Monocle estimated a pseudotime for each cell along the inferred cell trajectory within the state space showing a delayed activation pattern of “subset LPS” compared
to the other fractions.
C Pseudotime dynamics of inflammatory (Ccl12, Ccl2, Gpr84) and homeostatic (Mef2c, P2ry12, Siglech) genes in dependence on inferred cell states.
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resuspended in ice-cold HBSS with 2% FBS and 10 mM HEPES, pH
7.4 and filtered through a 70-lm nylon mesh (CellTrics). For multi-
colour staining, cells were incubated for 15 min with Fc receptor
binding inhibitor (anti-mouse CD16/CD32 monoclonal antibody;
1:100; eBioscience) to reduce binding of non-specific Fc-gamma
receptors, and then stained with fluorochrome-conjugated antibodies
(Appendix Table S2) or their corresponding isotopic controls for
45 min at 4°C in dark. After washing, cells were pelleted at 300 g for
10 min at 4°C and resuspended in 200 ll of the appropriated buffer.
Hoechst (0.1 lg/ml; Sigma) or Sytox Red (1:1,000; Thermo Fisher
Scientific) were added shortly before flow cytometry measurements
for dead cell discrimination. Cells were sorted with FACSAriaTM SORP
cytometer (BD Biosciences) fitted with a 640 nm (30 mW) red laser,
a 355 nm (60 mW) UV laser, a 405 nm (50 mW) violet laser, a
488 nm (100 mW) blue laser and a 561 nm (50 mW) yellow/green
laser. Data were analysed with FACSDiva software (Becton Dickin-
son) and FlowJo software (version 7.6.5; Tree Star). Imaging flow
cytometry was performed with an ImageStream imaging cytometer
(Amnis) fitted with a 375 UV laser, a 488 blue laser, a 561 yellow-
green laser, a 642 red laser and a 785 nm infrared laser. Acquisition
was performed with the INSPIRE software, and analysis was
performed using IDEAS image analysis software. Pictures were
taken at 60× magnification at low speed, high sensitivity mode.
Isolation of bone marrow monocytes
Monocytes were isolated from mouse bone marrow cells by using
the Monocyte Isolation Kit (Miltenyi Biotec) according to the manu-
facturer’s protocol.
Primary adult mouse microglial culture
Adult microglia were isolated from brains of C57BL/6N mice at age
6–10 weeks by magnetic separation. Mice were transcardially
perfused with ice-cold PBS under anaesthesia, and brains were
dissociated using the Neural Dissociation Kit P (MACS Miltenyi
Biotec) according to the manufacturer’s instruction. Microglia were
enriched by magnetic separation using CD11b+ beads (MACS
Miltenyi Biotec). Briefly, 1 × 107 cells were resuspended in 90 ll of
MACS buffer [Hank’s balanced salt solution (HBSS); Lonza] supple-
mented with 0.5% BSA (Sigma-Aldrich) and 2 mM EDTA and 10 ll
of CD11b MicroBeads (MACS Miltenyi Biotec). The cell suspension
was incubated at 4°C for 20 min, washed and pelleted in 500 ll of
MACS buffer at a density of 1 × 108 cells. The cell suspension was
applied into LS columns (MACS Miltenyi Biotec), and the CD11b+
fraction was eluted. Primary adult microglia were plated in 24-well
plates coated in poly-L-lysine (0.1 mg/ml solution; Sigma-Aldrich)
at a density of 2 × 105 cells/ml and grown in microglial culture
medium [Dulbecco’s modified Eagle’s medium (DMEM-F12 w/L-
glutamine w/15 mM HEPES; Biowest)] supplemented with 10%
foetal bovine serum (FBS; Gibco/Life Technologies), pen-strep
(100 U/ml/100 lg/ml; Gibco/Life Technologies), human recombi-
nant TGF-b (PeproTech) at a final concentration of 50 lg/ml and
mouse recombinant M-CSF (R&D Systems) at a final concentration
of 10 ng/ml. Cells were cultured for 5 days without changing
media. After 9 days of culture, cells were stimulated with
lipopolysaccharide (LPS from Escherichia coli 055:B5; Sigma-
Aldrich) at a final concentration of 1 ng/ml for 6 h.
Primary newborn mouse microglial culture
Murine primary microglial cells were isolated from newborn (P1–
P4) C57BL/6N mouse brains as previously described [69]. Brains
were dissected on ice. Subsequently, meninges and large blood
vessels were carefully removed and brains were pooled and minced
in cold Dulbecco’s phosphate buffered saline (PBS; Lonza). Tissue
dissociation was completed by 10 min of incubation in 2 mM EDTA
(Sigma-Aldrich). Cells were washed, centrifuged, seeded into six-
well plates coated with poly-L-lysine and allowed to attach and
grow in complete medium DMEM (Gibco/Life Technologies) supple-
mented with 10% FBS and pen-strep at 37°C in a water-saturated
atmosphere containing 5% CO2. The culture medium was renewed
after 3 days of culture. After 10 days, when cells reached conflu-
ence, the mixed glial monolayer was trypsinated (0.05% Trypsin–
EDTA; Gibco/Life Technologies) and microglial cells were purified
by magnetic cell sorting (MACS Miltenyi Biotec) following the
manufacturer’s instructions. Primary microglia were plated in 12-
well plates coated with poly-L-lysine (Sigma-Aldrich) at a density of
4 × 105 cells/ml. Twenty-four hours after plating, cells were acti-
vated with different compounds: LPS at a final concentration of
1 ng/ml, TGF-b at a final concentration of 50 lg/ml and M-CSF at a
final concentration of 10 ng/ml.
RNA isolation and RT–PCR
CD11b+CD45int cells were FACS-sorted directly to TRIzol LS, and
total RNA was extracted according to the manufacturer’s protocol
(Life Technologies). RNA from primary cells was extracted using
the RNeasy Mini Kit (QIAGEN), according to the manufacturer’s
instructions. RNA concentration was quantified by NanoDrop
(NanoDrop Technologies) and the quality assessed by the quotient
of the 28S to 18S ribosomal RNA electropherogram peak using a
bioanalyser (Agilent 2100; Agilent Technologies) using a RNA Pico
Chip (Agilent Technologies; only samples with RIN ≥ 7 were further
analysed). For cDNA synthesis, RNA was reverse-transcribed using
SuperScriptTM III reverse transcriptase (10,000 U; Invitrogen/Life
Technologies) with 1 ll (50 lM)/reaction oligo(dT)20 (25 lM;
Invitrogen/Life Technologies) as primer according to the manufac-
turer’s instructions. Reverse transcription was performed at 50°C for
60 min. Gene expression reaction mixtures contained 2 ll of diluted
cDNA, 10 ll of Fast SYBR Green Master Mix (Applied Biosystems/
Thermo Fisher Scientific) and 0.5 ll of each 10 lM forward and
reverse primers. PCRs were carried out in 96-well plates on a ViiATM
7 real-time PCR system (Applied Biosystems/Thermo Fisher Scien-
tific) using the following programme: 95°C for 20 s, 40 cycles at
95°C for 1 s and 60°C for 20 s. The sequences of the primers
designed using Primer-Blast tool are listed in Appendix Table S3.
Samples were run in duplicates, and the mean Ct (threshold cycle)
values were used to calculate the relative amount of product by the
DDCt method using Gapdh as housekeeping gene.
Immunohistochemistry
Under deep ketamine–dorbene anaesthesia, mice were transcar-
dially perfused with ice-cold PBS, post-fixed in 4% paraformalde-
hyde (PFA) for 48 h and stored at 4°C in 0.02% sodium azide/PBS
as preservative. Serialized parasagittal free-floating 50-lm-thick
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sections were generated with a vibratome (Leica; VT-1000S) and
collected in cryoprotective medium [PBS containing 1-1 ethylene
glycol (Sigma-Aldrich) and 1% w/v polyvinylpyrrolidone (Sigma-
Aldrich)]. Sections were stored at 20°C in tubes, each containing a
series of every 4th section.
For immunofluorescence, a standard protocol was used with
minor modifications [70]. Briefly, sections were washed (PBS with
0.1% Triton X-100), permeabilized (PBS with 1.5% Triton X-100),
blocked (PBS with 5% BSA) and incubated with primary antibodies
(PBS with 0.3% Triton X-100 and 2% BSA): rabbit anti-Iba1
(1:1,000; Wako) and pre-conjugated PE anti-mouse Notch4 (1:80;
BioLegend). Iba1 antibody was visualized using goat anti-rabbit IgG
Molecular Probes Alexa Fluor 555 (Thermo Fisher Scientific)
secondary antibody. Cell nuclei were counterstained with Hoechst
(1 lg/ml; Sigma). Sections were mounted on glass slides cover-
slipped using FluoromountTM Aqueous Mounting Medium (Sigma).
Microscopic images were obtained using confocal microscopy (Zeiss
LSM880).
SDS–PAGE and Western Blotting analysis
Heat-denatured protein samples were separated on 4–12% BisTris–
polyacrylamide gel electrophoresis followed by transfer to nitrocel-
lulose membranes 0.2 lm (Bio-Rad). After blocking with 5% (wt/
vol) dry milk in TBST for STAT3 and 3% BSA in TBST for Phospho-
STAT3, respectively, the membrane was incubated overnight at 4°C
in primary anti-STAT3 antibody from mouse (Cell Signaling) diluted
1:1,000 in 5% (wt/vol) dry milk in TBST and in primary anti-
Phospho-STAT3 antibody (Cell Signaling) diluted 1:500 in 3% BSA
in TBST with constant shaking. After three washing steps with TBS
containing 0.1% Tween-20, the membrane was incubated with anti-
rabbit antibody or anti-mouse respectively, coupled to horseradish
peroxidase and revealed by chemoluminescence using the PierceTM
ECL detection reagents (Thermo Fisher Scientific).
Single-cell RNA sequencing using Drop-seq
Cell preparation
FACS-sorted CD11b+CD45int cells were collected in pre-cooled HBSS
and 0.5% BSA and transferred directly for subsequent Drop-seq
analysis. The cells were stored on ice until the start of the Drop-seq
experiment (tissue harvest to running of Drop-seq was < 1 h). Prior
to cell loading on the Drop-seq chips, the cell viability was verified
and the concentration was adjusted to ~150 cells/ll. This was opti-
mal based on Poissonian statistics to achieve single-cell encapsula-
tion within each droplet of ~800–900 pl droplet size. All samples
analysed in this work had a cell viability > 95%.
Microfluidics fabrication
Microfluidics devices were generated using a previously published
design [23]. Soft lithography was performed using SU-8 2050
photoresist (MicroChem) on 4” silicon substrate to obtain a feature
aspect depth of 100 lm. After overnight silanization (using
chlorotrimethylsilane; Sigma), the wafer masks were used for
microfluidics fabrication. Drop-seq chips were fabricated using sili-
con-based polymerization chemistry, with the previously published
protocol [71]. Briefly, polydimethylsiloxane (PDMS) base and cross-
linker (Dow Corning) were mixed at a 10:1 ratio, mixed and
degassed before pouring onto the Drop-seq master template. PDMS
was cured on the master template, at 80°C for 2 h. After incubation
and cooling, PDMS monoliths were cut and the inlet/outlet ports
were punched with 1.25-mm biopsy punchers (World Precision
Instruments). The PDMS monolith was plasma-bonded to a clean
microscopic glass slide using a Harrick plasma cleaner. Immediately
after pairing the plasma-treated surfaces of the PDMS monolith and
the glass slide, flow channels of the Drop-seq chip were subjected to
a hydrophobicity treatment using 1H,1H,2H,2H-perfluorodecyltri-
chlorosilane (in 2% v/v in FC-40 oil; Alfa Aesar/Sigma). After
5 min of treatment, excessive silane was blown through the inlet/
outlet ports. Chips were further incubated at 80°C for 15 min.
Single-cell droplet encapsulation
Experiments followed the original Drop-seq protocol [23] with
minor changes described below. Synthesized barcoded beads
(ChemGenes Corp., USA) were co-encapsulated with cells inside the
droplets containing lysis reagents using an optimal bead concentra-
tion of 200 beads/ll in Drop-seq Lysis buffer medium. Cellular
mRNA was captured on the beads via barcoded oligo (dT) handles
synthesized on the surface.
For cell encapsulation, bead suspensions and cell suspension
were loaded into 3-ml syringes (BD). To keep beads in homoge-
nous suspension, a micro-stirrer was used (VP Scientific). The
QX200 carrier oil (Bio-Rad) used as continuous phase in the
droplet generation was loaded into a 20-ml syringe (BD). For
droplet generation, 3.6 ml/h and 13 ml/h flowrates were used in
KD Scientific Legato Syringe Pumps for the dispersed and continu-
ous phase flows, respectively. After stabilization of droplet forma-
tion, the droplet suspension was collected into a 50-ml Falcon
tube. Collection of the emulsion was carried out until 1 ml of the
single-cell suspension was dispensed. Droplet consistency and
stability were evaluated by bright-field microscopy using INCYTO
C-Chip Disposable Hemacytometer (Thermo Fisher Scientific).
Bead occupancy within droplets was carefully monitored to avoid
multiple beads per droplet.
The subsequent steps of droplet breakage, bead harvesting,
reverse transcription and exonuclease treatment were carried out in
accordance with the Drop-seq method [23]. RT buffer contained 1×
Maxima RT buffer, 4% Ficoll PM-400 (Sigma), 1 lM dNTPs
(Thermo Fisher Scientific), 1 U/ml RNase Inhibitor (Lucigen),
2.5 lM Template Switch Oligo [23] and 10 U/ml Maxima H-RT
(Thermo Fisher Scientific). After Exo-I treatment, the bead counts
were estimated using INCYTO C-Chip Disposable Hemacytometer,
and 5,000–8,000 beads were aliquoted in 0.2 ml Eppendorf PCR
tubes. PCR mix was dispensed in a volume of 50 ll using 1× HiFi
HotStart ReadyMix (Kapa Biosystems) and 0.8 mM Template Switch
PCR primer. The thermocycling programme for the PCR amplifi-
cation was modified for the final PCR cycles by 95°C (3 min), four
cycles of 98°C (20 s), 65°C (45 s), 72°C (3 min) and 16 cycles of
98°C (20 s), 67°C (20 s), 72°C (3 min), followed by a final extension
step of 72°C for 5 min. After PCR amplification, libraries were puri-
fied with 0.6× Agencourt AMPure XP beads (Beckman Coulter),
according to the manufacturer’s protocol. Finally, the purified
libraries were eluted in 20 ll RNase/DNase-free Molecular Grade
Water. Quality and concentration of the sequencing libraries
were assessed using Bioanalyzer High Sensitivity Chip (Agilent
Technologies).
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NGS preparation for Drop-seq libraries
The 30 end enriched cDNA libraries were prepared by tagmentation
reaction of 600 pg cDNA library using the standard Nextera XT
tagmentation kit (Illumina). Reactions were performed according to
the manufacturer’s instructions. The PCR amplification cycling
programme used was 95°C 30 s, and fourteen cycles of 95°C (10 s),
55°C (30 s) and 72°C (30 s), followed by a final extension step of
72°C (5 min). Libraries were purified twice to reduce primers and
short DNA fragments with 0.6× and 1× Agencourt AMPure XP beads
(Beckman Coulter), respectively, in accordance with the manufac-
turer’s protocol. Finally, purified libraries were eluted in 15 ll Mole-
cular Grade Water. Quality and quantity of the tagmented cDNA
library were evaluated using Bioanalyzer High Sensitivity DNA
Chip. The average size of the tagmented libraries prior to sequenc-
ing was between 400 and 700 bps.
Purified Drop-seq cDNA libraries were sequenced using Illumina
NextSeq 500 with the recommended sequencing protocol except for
6pM of custom primer (GCCTGTCCGCGGAAGCAGTGGTATCAACG
CAGAGTAC) applied for priming of read 1. Paired-end sequencing
was performed for the read 1 of 20 bases (covering the random cell
barcode 1–12 bases and the rest 13–20 bases of random unique
molecular identifier (UMI) and for read 2 of 50 bases of the genes.
Bioinformatics processing and data analysis
The FASTQ files were assembled from the raw BCL files using Illu-
mina’s bcl2fastq converter and ran through the FASTQC codes
(Babraham bioinformatics; https://www.bioinformatics.babraham.
ac.uk/projects/fastqc/) to check for consistency in library qualities.
The monitored quality assessment parameters were (i) quality per
base sequence (especially for the read 2 of the gene), (ii) per base N
content, (iii) per base sequence content, and (iv) over-represented
sequences. Libraries that showed significant deviation were re-
sequenced. The FASTQ files were then merged and converted into
binaries using PICARD’s FastqToSam algorithm. The sequencing
reads were converted into a digital gene expression matrix using the
Drop-seq bioinformatics pipeline [23].
Data analysis was done in R. Cells with less than 1,000 counts and
genes with zero count in all cells were excluded from subsequent
analyses, resulting in 1,247 cells (477 from the saline control and 770
from LPS-injected mice) and 12,369 genes. PCA (prcomp function with
scaling) was used for dimensionality reduction, and PCA results were
projected onto a two-dimensional (2D) space using t-distributed
stochastic neighbour embedding (tSNE, tsne package, v.0.1-3). As the
first principal component was strongly correlated to the total number
of UMI (reads) per cell, it was not included in the 2D-tSNE analysis.
Differential expression analysis was performed with MAST [57]. P-
values were adjusted for multiple testing using false discovery rate
(FDR) [72]. Prior to MAST analysis, counts were converted into
counts per million and log2-transformed. For subpopulation identifi-
cation, two approaches were used: (i) based on visual inspection of
2D-tSNE plot, cells were divided into three clusters: one cluster
contained almost exclusively cells isolated from control mice, another
cluster contained mainly cells harvested from LPS-injected mice, and
the last cluster was constituted of a small subset of LPS-derived cells.
Clusters were pruned to keep only cells coming from the predominant
sample in the group. Comparisons of gene expression between dif-
ferent groups were done with the Kruskal–Wallis H-test. P-values were
corrected with FDR [72]; (ii) each condition was analysed separately
with the “SC3” package [67]. Branching analysis was performed by
Monocle 2.4.0 in R (version 3.4.4) with standard parameters [68,73].
The branching method orders cells along an estimated cell trajectory
within a gene expression state space based on gene expression simi-
larities estimated by generalized linear regression models.
Statistical analysis
Statistical analyses for qPCRs and FACS experiments were performed
using GraphPad Prism 7 software. Comparisons of two groups were
performed with a two-tailed Student’s t-test. Comparisons involving
more than two groups were performed using one-way ANOVA
followed by the Bonferroni correction for multiple testing. All dif-
ferences were considered significantly different at P < 0.05. Further
statistical analysis details are reported in the figure legends.
Data availability
Single-cell RNA sequencing data have been deposited in Gene
Expression Omnibus (GEO) database under the accession number
GSE115571 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=
GSE115571).
Expanded View for this article is available online.
Acknowledgements
We thank Dr. Coralie Guérin and Dr. Léa Guyonnet for helping with flow cytom-
etry experiments as well as Eliane Klein for Western blot analyses. We are grate-
ful to Dr. Tony Heurtaux for technical assistance with cultivated microglial as
well as Oihane Uriarte and Dr. Manuel Buttini for immunohistochemistry analy-
ses. C.S. was supported by the Luxembourg National Research Fund (AFR project
reference 6916713) and the Fondation du Pélican de Mie et Pierre Hippert-Faber
Under the Aegis of Fondation de Luxembourg. Y.P.A. and S.M. were supported by
the Luxembourg National Research Fund (PRIDE15/10675146 and PRIDE16/
10907093, respectively). A.S. was supported by the C14/BM/7975668/CaSCAD
project as well as by the National Biomedical Computation Resource (NBCR)
through the NIH P41 GM103426 grant from the National Institutes of Health.
We acknowledge financial support by the Luxembourg Institute of Health
(MIGLISYS) and the Luxembourg Centre for Systems Biomedicine.
Author contributions
CS and AM designed the project; KB, RB and SPN involved in the experimental
design; CS, SKP, YP-A and AM performed experiments; CS, AG, SKP, TK, SM, AS
and AM analysed experiments; DC provided animals; FA supervised the bioin-
formatics analyses of the single-cell RNA-seq; CS and AM wrote the manu-
script; and AG, SKP, TK, DC, YP-A, SM, FA, AS, RB, KB and SPN edited and
approved the manuscript.
Conflict of interest
The authors declare that they have no conflict of interest.
References
1. Prinz M, Priller J (2014) Microglia and brain macrophages in the molec-
ular age: from origin to neuropsychiatric disease. Nat Rev Neurosci 15:
300 – 312
14 of 17 EMBO reports 19: e46171 | 2018 ª 2018 The Authors
EMBO reports Single-cell inflammatory microglial Carole Sousa et al
Published online: September 11, 2018 
2. Sousa C, Biber K, Michelucci A (2017) Cellular and molecular characteri-
zation of microglia: a unique immune cell population. Front Immunol 8:
198
3. Gautier EL, Shay T, Miller J, Greter M, Jakubzick C, Ivanov S, Helft J,
Chow A, Elpek KG, Gordonov S et al (2012) Gene-expression profiles
and transcriptional regulatory pathways that underlie the identity
and diversity of mouse tissue macrophages. Nat Immunol 13:
1118 – 1128
4. Hickman SE, Kingery ND, Ohsumi TK, Borowsky ML, Wang LC, Means TK,
El Khoury J (2013) The microglial sensome revealed by direct RNA
sequencing. Nat Neurosci 16: 1896 – 1905
5. Butovsky O, Jedrychowski MP, Moore CS, Cialic R, Lanser AJ, Gabriely G,
Koeglsperger T, Dake B, Wu PM, Doykan CE et al (2014) Identification of
a unique TGF-beta-dependent molecular and functional signature in
microglia. Nat Neurosci 17: 131 – 143
6. Zhang Y, Chen K, Sloan SA, Bennett ML, Scholze AR, O’Keeffe S, Phatnani
HP, Guarnieri P, Caneda C, Ruderisch N et al (2014) An RNA-sequencing
transcriptome and splicing database of glia, neurons, and vascular cells
of the cerebral cortex. J Neurosci 34: 11929 – 11947
7. Butovsky O, Jedrychowski MP, Cialic R, Krasemann S, Murugaiyan G,
Fanek Z, Greco DJ, Wu PM, Doykan CE, Kiner O et al (2015) Targeting
miR-155 restores abnormal microglia and attenuates disease in SOD1
mice. Ann Neurol 77: 75 – 99
8. Elliott R, Li F, Dragomir I, Chua MM, Gregory BD, Weiss SR (2013) Analy-
sis of the host transcriptome from demyelinating spinal cord of murine
coronavirus-infected mice. PLoS One 8: e75346
9. Holtman IR, Raj DD, Miller JA, Schaafsma W, Yin Z, Brouwer N, Wes PD,
Moller T, Orre M, Kamphuis W et al (2015) Induction of a common
microglia gene expression signature by aging and neurodegenerative
conditions: a co-expression meta-analysis. Acta Neuropathol Commun 3:
31
10. Lewis ND, Hill JD, Juchem KW, Stefanopoulos DE, Modis LK (2014) RNA
sequencing of microglia and monocyte-derived macrophages from mice
with experimental autoimmune encephalomyelitis illustrates a changing
phenotype with disease course. J Neuroimmunol 277: 26 – 38
11. Olah M, Amor S, Brouwer N, Vinet J, Eggen B, Biber K, Boddeke HW
(2012) Identification of a microglia phenotype supportive of remyelina-
tion. Glia 60: 306 – 321
12. Verheijden S, Beckers L, Casazza A, Butovsky O, Mazzone M, Baes M
(2015) Identification of a chronic non-neurodegenerative microglia acti-
vation state in a mouse model of peroxisomal beta-oxidation deficiency.
Glia 63: 1606 – 1620
13. Wang Y, Cella M, Mallinson K, Ulrich JD, Young KL, Robinette ML, Gilfil-
lan S, Krishnan GM, Sudhakar S, Zinselmeyer BH et al (2015) TREM2
lipid sensing sustains the microglial response in an Alzheimer’s disease
model. Cell 160: 1061 – 1071
14. Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Sztern-
feld R, Ulland TK, David E, Baruch K, Lara-Astaiso D, Toth B et al (2017)
A unique microglia type associated with restricting development of
Alzheimer’s disease. Cell 169: 1276 – 1290 e17
15. Krasemann S, Madore C, Cialic R, Baufeld C, Calcagno N, El Fatimy R,
Beckers L, O’Loughlin E, Xu Y, Fanek Z et al (2017) The TREM2-APOE
pathway drives the transcriptional phenotype of dysfunctional microglia
in neurodegenerative diseases. Immunity 47: 566 – 581 e9
16. Chiu IM, Morimoto ET, Goodarzi H, Liao JT, O’Keeffe S, Phatnani HP,
Muratet M, Carroll MC, Levy S, Tavazoie S et al (2013) A neurodegenera-
tion-specific gene-expression signature of acutely isolated microglia from
an amyotrophic lateral sclerosis mouse model. Cell Rep 4: 385 – 401
17. Orre M, Kamphuis W, Osborn LM, Jansen AHP, Kooijman L, Bossers K,
Hol EM (2014) Isolation of glia from Alzheimer’s mice reveals inflamma-
tion and dysfunction. Neurobiol Aging 35: 2746 – 2760
18. Norden DM, Godbout JP (2013) Review: microglia of the aged brain:
primed to be activated and resistant to regulation. Neuropathol Appl
Neurobiol 39: 19 – 34
19. Crotti A, Ransohoff RM (2016) Microglial physiology and pathophysiol-
ogy: insights from genome-wide transcriptional profiling. Immunity 44:
505 – 515
20. Fullerton JN, Gilroy DW (2016) Resolution of inflammation: a new thera-
peutic frontier. Nat Rev Drug Discov 15: 551 – 567
21. Wyss-Coray T, Mucke L (2002) Inflammation in neurodegenerative
disease–a double-edged sword. Neuron 35: 419 – 432
22. Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH (2010) Mechanisms
underlying inflammation in neurodegeneration. Cell 140: 918 – 934
23. Macosko EZ, Basu A, Satija R, Nemesh J, Shekhar K, Goldman M, Tirosh I,
Bialas AR, Kamitaki N, Martersteck EM et al (2015) Highly parallel
genome-wide expression profiling of individual cells using nanoliter
droplets. Cell 161: 1202 – 1214
24. Shalek AK, Satija R, Adiconis X, Gertner RS, Gaublomme JT, Raychowd-
hury R, Schwartz S, Yosef N, Malboeuf C, Lu D et al (2013) Single-cell
transcriptomics reveals bimodality in expression and splicing in immune
cells. Nature 498: 236 – 240
25. Tang F, Barbacioru C, Wang Y, Nordman E, Lee C, Xu N, Wang X, Bodeau
J, Tuch BB, Siddiqui A et al (2009) mRNA-Seq whole-transcriptome anal-
ysis of a single cell. Nat Methods 6: 377 – 382
26. Tasic B, Menon V, Nguyen TN, Kim TK, Jarsky T, Yao Z, Levi B, Gray LT,
Sorensen SA, Dolbeare T et al (2016) Adult mouse cortical cell
taxonomy revealed by single cell transcriptomics. Nat Neurosci 19:
335 – 346
27. Mathys H, Adaikkan C, Gao F, Young JZ, Manet E, Hemberg M, De Jager
PL, Ransohoff RM, Regev A, Tsai LH (2017) Temporal tracking of micro-
glia activation in neurodegeneration at single-cell resolution. Cell Rep
21: 366 – 380
28. Dulken BW, Leeman DS, Boutet SC, Hebestreit K, Brunet A (2017) Single-
cell transcriptomic analysis defines heterogeneity and transcriptional
dynamics in the adult neural stem cell lineage. Cell Rep 18: 777 – 790
29. Chen R, Wu X, Jiang L, Zhang Y (2017) Single-cell RNA-seq reveals
hypothalamic cell diversity. Cell Rep 18: 3227 – 3241
30. Artegiani B, Lyubimova A, Muraro M, van Es JH, van Oudenaarden A,
Clevers H (2017) A single-cell RNA sequencing study reveals cellular and
molecular dynamics of the hippocampal neurogenic niche. Cell Rep 21:
3271 – 3284
31. Jaitin DA, Weiner A, Yofe I, Lara-Astiaso D, Keren-Shaul H, David E,
Salame TM, Tanay A, van Oudenaarden A, Amit I (2016) Dissecting
immune circuits by linking CRISPR-pooled screens with single-cell RNA-
seq. Cell 167: 1883 – 1896 e15
32. Bennett ML, Bennett FC, Liddelow SA, Ajami B, Zamanian JL, Fernhoff
NB, Mulinyawe SB, Bohlen CJ, Adil A, Tucker A et al (2016) New tools for
studying microglia in the mouse and human CNS. Proc Natl Acad Sci
USA 113: E1738 – E1746
33. Qin L, Wu X, Block ML, Liu Y, Breese GR, Hong JS, Knapp DJ, Crews FT
(2007) Systemic LPS causes chronic neuroinflammation and progressive
neurodegeneration. Glia 55: 453 – 462
34. Dantzer R (2001) Cytokine-induced sickness behavior: mechanisms and
implications. Ann N Y Acad Sci 933: 222 – 234
35. Bodea LG, Wang Y, Linnartz-Gerlach B, Kopatz J, Sinkkonen L, Musgrove
R, Kaoma T, Muller A, Vallar L, Di Monte DA et al (2014)
ª 2018 The Authors EMBO reports 19: e46171 | 2018 15 of 17
Carole Sousa et al Single-cell inflammatory microglial EMBO reports
Published online: September 11, 2018 
Neurodegeneration by activation of the microglial complement-phago-
some pathway. J Neurosci 34: 8546 – 8556
36. Ransohoff RM (2016) A polarizing question: do M1 and M2 microglia
exist? Nat Neurosci 19: 987 – 991
37. Sedgwick JD, Schwender S, Imrich H, Dorries R, Butcher GW, ter Meulen
V (1991) Isolation and direct characterization of resident microglial cells
from the normal and inflamed central nervous system. Proc Natl Acad
Sci USA 88: 7438 – 7442
38. Goldmann T, Wieghofer P, Jordao MJ, Prutek F, Hagemeyer N, Frenzel K,
Amann L, Staszewski O, Kierdorf K, Krueger M et al (2016) Origin, fate
and dynamics of macrophages at central nervous system interfaces. Nat
Immunol 17: 797 – 805
39. Michelucci A, Heurtaux T, Grandbarbe L, Morga E, Heuschling P (2009)
Characterization of the microglial phenotype under specific pro-inflam-
matory and anti-inflammatory conditions: effects of oligomeric and fib-
rillar amyloid-beta. J Neuroimmunol 210: 3 – 12
40. Beutner C, Linnartz-Gerlach B, Schmidt SV, Beyer M, Mallmann MR,
Staratschek-Jox A, Schultze JL, Neumann H (2013) Unique transcriptome
signature of mouse microglia. Glia 61: 1429 – 1442
41. Haynes SE, Hollopeter G, Yang G, Kurpius D, Dailey ME, Gan WB, Julius
D (2006) The P2Y12 receptor regulates microglial activation by extracel-
lular nucleotides. Nat Neurosci 9: 1512 – 1519
42. Gosselin D, Link VM, Romanoski CE, Fonseca GJ, Eichenfield DZ, Spann
NJ, Stender JD, Chun HB, Garner H, Geissmann F et al (2014) Environ-
ment drives selection and function of enhancers controlling tissue-
specific macrophage identities. Cell 159: 1327 – 1340
43. Lavin Y, Winter D, Blecher-Gonen R, David E, Keren-Shaul H, Merad M,
Jung S, Amit I (2014) Tissue-resident macrophage enhancer landscapes
are shaped by the local microenvironment. Cell 159: 1312 – 1326
44. Matcovitch-Natan O, Winter DR, Giladi A, Vargas Aguilar S, Spinrad A,
Sarrazin S, Ben-Yehuda H, David E, Zelada Gonzalez F, Perrin P et al
(2016) Microglia development follows a stepwise program to regulate
brain homeostasis. Science 353: aad8670
45. Deczkowska A, Matcovitch-Natan O, Tsitsou-Kampeli A, Ben-Hamo S,
Dvir-Szternfeld R, Spinrad A, Singer O, David E, Winter DR, Smith LK
et al (2017) Mef2C restrains microglial inflammatory response and is
lost in brain ageing in an IFN-I-dependent manner. Nat Commun 8: 717
46. Flanders KC, Ludecke G, Engels S, Cissel DS, Roberts AB, Kondaiah P,
Lafyatis R, Sporn MB, Unsicker K (1991) Localization and actions of
transforming growth factor-beta s in the embryonic nervous system.
Development 113: 183 – 191
47. Hamby ME, Hewett JA, Hewett SJ (2010) Smad3-dependent signaling
underlies the TGF-beta1-mediated enhancement in astrocytic iNOS
expression. Glia 58: 1282 – 1291
48. Lindholm D, Castren E, Kiefer R, Zafra F, Thoenen H (1992) Transforming
growth factor-beta 1 in the rat brain: increase after injury and inhibi-
tion of astrocyte proliferation. J Cell Biol 117: 395 – 400
49. Wang X, Chen W, Liu W, Wu J, Shao Y, Zhang X (2009) The role of
thrombospondin-1 and transforming growth factor-beta after spinal
cord injury in the rat. J Clin Neurosci 16: 818 – 821
50. Klempt ND, Sirimanne E, Gunn AJ, Klempt M, Singh K, Williams C, Gluck-
man PD (1992) Hypoxia-ischemia induces transforming growth factor
beta 1 mRNA in the infant rat brain. Brain Res Mol Brain Res 13:
93 – 101
51. Flanders KC, Ren RF, Lippa CF (1998) Transforming growth factor-betas
in neurodegenerative disease. Prog Neurobiol 54: 71 – 85
52. Dobolyi A, Vincze C, Pal G, Lovas G (2012) The neuroprotective functions
of transforming growth factor beta proteins. Int J Mol Sci 13: 8219 – 8258
53. Wang G, Yu Y, Sun C, Liu T, Liang T, Zhan L, Lin X, Feng XH (2016) STAT3
selectively interacts with Smad3 to antagonize TGF-beta. Oncogene 35:
4388 – 4398
54. Carow B, Rottenberg ME (2014) SOCS3, a major regulator of infection
and inflammation. Front Immunol 5: 58
55. Rouillard AD, Gundersen GW, Fernandez NF, Wang Z, Monteiro CD,
McDermott MG, Ma’ayan A (2016) The harmonizome: a collection of
processed datasets gathered to serve and mine knowledge about genes
and proteins. Database (Oxford) 2016: baw100
56. Colonna M, Butovsky O (2017) Microglia function in the central nervous
system during health and neurodegeneration. Annu Rev Immunol 35:
441 – 468
57. Finak G, McDavid A, Yajima M, Deng J, Gersuk V, Shalek AK, Slichter
CK, Miller HW, McElrath MJ, Prlic M et al (2015) MAST: a flexible
statistical framework for assessing transcriptional changes and
characterizing heterogeneity in single-cell RNA sequencing data.
Genome Biol 16: 278
58. Huang DW, Sherman BT, Lempicki RA (2008) Systematic and integrative
analysis of large gene lists using DAVID bioinformatics resources. Nat
Protoc 4: 44
59. Huang DW, Sherman BT, Lempicki RA (2009) Bioinformatics enrichment
tools: paths toward the comprehensive functional analysis of large gene
lists. Nucleic Acids Res 37: 1 – 13
60. Hsieh CL, Koike M, Spusta SC, Niemi EC, Yenari M, Nakamura MC,
Seaman WE (2009) A role for TREM2 ligands in the phagocytosis
of apoptotic neuronal cells by microglia. J Neurochem 109:
1144 – 1156
61. Takahashi K, Rochford CD, Neumann H (2005) Clearance of apoptotic
neurons without inflammation by microglial triggering receptor
expressed on myeloid cells-2. J Exp Med 201: 647 – 657
62. Zheng H, Jia L, Liu CC, Rong Z, Zhong L, Yang L, Chen XF, Fryer JD, Wang
X, Zhang YW et al (2017) TREM2 promotes microglial survival by acti-
vating Wnt/beta-Catenin pathway. J Neurosci 37: 1772 – 1784
63. Safaiyan S, Kannaiyan N, Snaidero N, Brioschi S, Biber K, Yona S, Edinger
AL, Jung S, Rossner MJ, Simons M (2016) Age-related myelin degradation
burdens the clearance function of microglia during aging. Nat Neurosci
19: 995 – 998
64. Streit WJ, Braak H, Xue QS, Bechmann I (2009) Dystrophic (senescent)
rather than activated microglial cells are associated with tau pathology
and likely precede neurodegeneration in Alzheimer’s disease. Acta
Neuropathol 118: 475 – 485
65. Neves J, Zhu J, Sousa-Victor P, Konjikusic M, Riley R, Chew S, Qi Y,
Jasper H, Lamba DA (2016) Immune modulation by MANF promotes
tissue repair and regenerative success in the retina. Science 353:
aaf3646
66. Xia M, Liu J, Wu X, Liu S, Li G, Han C, Song L, Li Z, Wang Q, Wang J et al
(2013) Histone methyltransferase Ash1 l suppresses interleukin-6
production and inflammatory autoimmune diseases by inducing the
ubiquitin-editing enzyme A20. Immunity 39: 470 – 481
67. Kiselev VY, Kirschner K, Schaub MT, Andrews T, Yiu A, Chandra T,
Natarajan KN, Reik W, Barahona M, Green AR et al (2017) SC3:
consensus clustering of single-cell RNA-seq data. Nat Methods 14:
483 – 486
68. Qiu X, Hill A, Packer J, Lin D, Ma YA, Trapnell C (2017) Single-cell mRNA
quantification and differential analysis with Census. Nat Methods 14:
309 – 315
69. Losciuto S, Dorban G, Gabel S, Gustin A, Hoenen C, Grandbarbe L,
Heuschling P, Heurtaux T (2012) An efficient method to limit
16 of 17 EMBO reports 19: e46171 | 2018 ª 2018 The Authors
EMBO reports Single-cell inflammatory microglial Carole Sousa et al
Published online: September 11, 2018 
microglia-dependent effects in astroglial cultures. J Neurosci Methods
207: 59 – 71
70. Buttini M, Orth M, Bellosta S, Akeefe H, Pitas RE, Wyss-Coray T, Mucke
L, Mahley RW (1999) Expression of human apolipoprotein E3 or E4 in
the brains of Apoe-/- mice: isoform-specific effects on neurodegenera-
tion. J Neurosci 19: 4867 – 4880
71. Mazutis L, Gilbert J, Ung WL, Weitz DA, Griffiths AD, Heyman JA (2013)
Single-cell analysis and sorting using droplet-based microfluidics. Nat
Protoc 8: 870 – 891
72. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a
practical and powerful approach to multiple testing. J R Stat Soc B
Methodol 57: 289 – 300
73. Trapnell C, Cacchiarelli D, Grimsby J, Pokharel P, Li S, Morse M, Lennon
NJ, Livak KJ, Mikkelsen TS, Rinn JL (2014) The dynamics and regulators
of cell fate decisions are revealed by pseudotemporal ordering of single
cells. Nat Biotechnol 32: 381 – 386
License: This is an open access article under the
terms of the Creative Commons Attribution-
NonCommercial-NoDerivs 4.0 License, which permits
use and distribution in any medium, provided the
original work is properly cited, the use is non-
commercial and no modifications or adaptations are
made.
ª 2018 The Authors EMBO reports 19: e46171 | 2018 17 of 17
Carole Sousa et al Single-cell inflammatory microglial EMBO reports
Published online: September 11, 2018 
